Lean PCOS - Postgraduate Answer

Definition

Why It Matters

Pathophysiology in Lean PCOS

1. Intrinsic Insulin Resistance (not obesity-driven)

• IR in PCOS is not solely explained by obesity. Lean women with PCOS have a post-receptor defect in insulin signaling - specifically, diminished autophosphorylation of the insulin receptor (identified in ~50% of PCOS women)
• This is an intrinsic, primary defect in insulin action, independent of body weight
• Hyperinsulinemia remains present even in lean patients, though at lower absolute levels than obese PCOS
• ~10% of nonobese PCOS women show impaired glucose tolerance (IGT) on 2-hour GTT, compared to 40-50% in obese PCOS

2. Hyperandrogenism

• Insulin (in collaboration with LH) enhances theca cell androgen production
• Insulin also inhibits hepatic synthesis of sex hormone-binding globulin (SHBG), increasing free (bioavailable) testosterone
• Serum total testosterone is usually no more than twice the upper normal limit (20-80 ng/dL)
• The adrenal compartment contributes: DHEAS is elevated in ~50% of PCOS patients regardless of BMI
• The CYP17 hyperresponsiveness (17,20-lyase activation during adrenarche) is a key shared mechanism

3. Gonadotropin Dysregulation

• Increased LH pulse frequency relative to FSH - a hallmark regardless of weight
• This results in the elevated LH:FSH ratio (though not a major diagnostic criterion, it is commonly seen)
• LH excess drives thecal androgen excess while relative FSH deficiency impairs follicular maturation

4. Peripheral Compartment (Less Active in Lean)

• In lean women, peripheral aromatization of androstenedione to estrone (E1) is less exaggerated compared to obese patients (who have increased aromatase activity in fat cells)
• The E1:E2 ratio reversal is less pronounced

Rotterdam Diagnostic Criteria (2003) - Applied to Lean PCOS

1. Oligoovulation or anovulation
2. Clinical and/or biochemical signs of hyperandrogenism (hirsutism, acne, elevated androgens)
3. Polycystic ovarian morphology on ultrasound: ≥20 follicles in either ovary (2-9 mm) and/or ovarian volume >10 mL

Clinical Features of Lean PCOS

• Acanthosis nigricans is a reliable marker of IR in hirsute women - its absence in lean PCOS does not exclude IR
• The HAIR-AN syndrome (Hyperandrogenism, Insulin Resistance, Acanthosis Nigricans) is more typical of the obese/severe phenotype

Metabolic Screening in Lean PCOS

• OGTT (75 g, 2-hour) is recommended in lean PCOS women with any of the following risk factors:
  • Age ≥ 40 years
  • Personal history of gestational diabetes
  • Family history of type 2 diabetes mellitus
• Fasting glucose-to-insulin ratio < 4.5 indicates IR even in lean patients
• Peak insulin > 150 IU/mL or mean insulin > 84 IU/mL over 3 draws suggests significant hyperinsulinemia
• Lipid profile should be checked (reassessed every 2 years if normal)
• Blood pressure at each visit
• Screening for depression and anxiety (increased in PCOS regardless of weight)

Management

Lifestyle

• Lifestyle modification remains first-line but the emphasis differs - the goal is not weight loss but maintaining metabolic health, improving insulin sensitivity, and regular physical activity (exercise reduces IR independent of weight loss)

Menstrual Regulation / Endometrial Protection

• Combined oral contraceptive pills (COCPs): First-line for cycle regulation and androgen suppression - increase SHBG, reduce free testosterone
• Progestins (medroxyprogesterone 10 mg for 10-14 days every 3 months, or levonorgestrel IUD): Endometrial protection from unopposed estrogen

Hyperandrogenism

• COCPs remain first-line
• After 6 months of inadequate response: Antiandrogens - spironolactone, flutamide

Insulin Sensitizers - Key Controversy in Lean PCOS

• Metformin is recommended for prevention of cardiometabolic risk in overweight/obese women with PCOS
• In lean PCOS, metformin may still be used if there is demonstrated IR or metabolic risk, but it is not recommended as monotherapy for endometrial protection, infertility, or prevention of gestational diabetes
• Benefit in lean PCOS is less clearly established than in obese PCOS

Ovulation Induction (if fertility desired)

• Letrozole (aromatase inhibitor) - first-line for ovulation induction
• Clomiphene citrate (SERM) - second-line, with or without metformin
• Injectable gonadotropins - used cautiously due to risk of ovarian hyperstimulation syndrome (OHSS); lean women with PCOS may paradoxically be at higher risk for OHSS given high antral follicle counts and elevated AMH
• Metformin as adjunct is less useful in lean patients

High-Yield Points for PG Exams

1. Lean PCOS = 20-30% of all PCOS - BMI < 25 (< 23 Asian)
2. The IR in lean PCOS is intrinsic (post-receptor defect), not obesity-driven
3. Diagnosis uses the same Rotterdam criteria - lean women often have milder phenotypes (phenotype 3 or 4)
4. 10% of nonobese PCOS have IGT on OGTT vs 40-50% of obese PCOS
5. OGTT is still indicated in lean PCOS with age ≥40, GDM history, or family history of T2DM
6. Acanthosis nigricans absent does not rule out IR in lean PCOS
7. Metformin is less beneficial in lean PCOS compared to obese PCOS
8. Letrozole > Clomiphene for ovulation induction
9. Lean PCOS women are at increased risk for OHSS due to high follicle count/AMH
10. Lifestyle modification is first-line but goal is not weight loss - it is insulin sensitization

Actinomycosis - Short Answer (PG Level)

Organism

• Gram-positive, filamentous, branching, pleomorphic bacillus
• Non-spore-forming, non-acid-fast, anaerobic or microaerophilic
• Not a fungus - despite "myces" in the name, it is a true bacterium
• Fastidious - requires enriched media, 6-10% CO2, takes 2-3 weeks to grow in culture
• Endogenous flora of oral cavity, lower GI tract, bronchi, and female genital tract - no external environmental reservoir, no person-to-person transmission

Epidemiology

• Worldwide; relatively rare (< 100 reported cases/year in the US - but true incidence is higher due to frequent misdiagnosis)
• Male : Female = 3:1 (due to higher prevalence of poor oral hygiene and oral trauma in men)
• Most common in middle decades of life; rare in children and >60 years

• Dental caries, extractions, gingivitis, oral trauma
• IUD use > 2 years (pelvic actinomycosis)
• Aspiration in smokers with poor oral hygiene (pulmonary)
• Mucosal breach - surgery, trauma, perforated appendix, diverticulitis
• Immunosuppression: corticosteroids, HIV, leukemia, transplant, alcoholism

Pathobiology

• Actinomyces are low-pathogenicity organisms that require mucosal barrier disruption to cause disease
• Usually occurs in immunocompetent persons
• Infection is polymicrobial - co-pathogens (Actinobacillus, Eikenella, Fusobacterium, Bacteroides, streptococci) help by inhibiting host defenses and reducing local oxygen tension
• Spreads contiguously, crossing fascial planes and anatomic barriers (does NOT spread via lymphatics)
• Results in chronic indurated, suppurative infection with fibrosis and draining sinuses
• The fibrotic "wooden" mass can easily be mistaken for malignancy
• Hematogenous spread is rare but can be fulminant

Sulfur Granules - The Pathognomonic Feature

• Sulfur granules = macroscopic/microscopic clusters (1-2 mm) of tangled Actinomyces filaments
• Appear pale yellow in pus (resembling sulfur - hence the name)
• Composition: aggregates of organisms + calcium phosphate
• Histology: basophilic center with eosinophilic peripheral clubs (Splendore-Hoeppli phenomenon)
• Present in only ~25% of drainage specimens - absence does NOT exclude diagnosis
• Special stains needed: Brown-Brenn, Gram, Giemsa, Gomori stains reveal filamentous structures
• NOT acid-fast (unlike Nocardia, which is weakly acid-fast - key differentiator on Fite-modified acid-fast stain)

Clinical Manifestations (by site)

1. Cervicofacial (Most Common - 55%)

• Odontogenic origin (dental caries, extraction)
• Chronic, slowly progressive, painless indurated swelling in submandibular/paramandibular area
• "Lumpy jaw" - woody, ligneous consistency
• Progresses to multiple abscesses and draining sinus tracts
• Sulfur granules may be present in discharge (~25%)
• Can extend to carotid artery, tongue, sinuses, mastoid, orbit, intracranially

2. Thoracic (~15%)

• Results from aspiration of oropharyngeal secretions
• Presents as chronic pneumonitis/mass lesion - mimics tuberculosis, malignancy, or Nocardiosis
• Symptoms: chest pain, productive cough, dyspnea, weight loss, fever
• Can extend through chest wall forming empyema and cutaneous sinuses
• Rib destruction possible (also seen in blastomycosis, but actinomycosis forms sinuses)

3. Abdominal (~20%)

• Follows mucosal breach (perforated appendix, surgery, trauma, neoplasia)
• Ileocecal region most commonly affected (after perforated appendix)
• CT shows infiltrative mass with dense inhomogeneous contrast enhancement
• Fibrotic mass simulates tumor - classic diagnostic pitfall
• Persistent perianal draining sinuses can simulate Crohn's disease
• Can extend to liver, retroperitoneum, spine, abdominal wall

4. Pelvic

• Classic association: IUD use > 2 years
• Manifestations range from chronic vaginal discharge to pelvic inflammatory disease with tubo-ovarian abscesses
• Can progress to pseudomalignant masses
• Sequence: endometritis → tubo-ovarian abscess → extension to uterus, bladder, rectal area, peritoneum

5. CNS (Rare)

• Single or multiple brain abscesses (ring-enhancing on CT)
• Actinomycotic meningitis = pachymeningitis (dural thickening)
• CSF pleocytosis is lymphocytic - mimics tuberculous meningitis

Diagnosis

• Tissue/pus is the best specimen (not swabs)
• Anaerobic culture on thioglycolate medium with rabbit serum at 35°C for up to 14 days
• Colony morphology: "molar tooth" colony on agar (A. israelii); clumpy in broth; A. odontolyticus forms red/rusty colonies
• Indole-negative
• PCR, 16S rRNA sequencing, mass spectrometry (MALDI-TOF) are modern confirmatory tools
• Histopathology: sulfur granules + filamentous branching organisms on Gram stain
• Key differentiator from Nocardia: Actinomyces is acid-fast NEGATIVE

Treatment

• Penicillin G = Drug of choice - no acquired resistance reported
• Alternative antibiotics: tetracycline, erythromycin, clindamycin, ceftriaxone, imipenem, fluoroquinolones
• Amoxicillin-clavulanate offers advantage of covering penicillinase-producing co-pathogens
• Ineffective drugs (AVOID): metronidazole, aminoglycosides, oxacillin, cephalexin
• Cervicofacial/limited disease: shorter course may suffice
• Extensive pulmonary/abdominal disease: 12-18 months required
• IUD-related pelvic actinomycosis: remove IUD + 2-week antibiotic course (longer if severe)
• Surgical drainage of abscesses when needed; surgical excision if malignancy cannot be excluded

Key High-Yield Points